RSS Feed – News

Its second, EHP-102, is focused on treating Huntington's disease and Parkinson's disease. The company is completing preclinical development for EHP-101 with the intent to launch a Phase 1 clinical study in 2018. For more information, visit www.emeraldpharma.life or contact: info@emeraldpharma.life. ... read more

“Huntington's Disease Epidemiology Market Forecast, 2027” report provides a comprehensive analysis of the Huntington's Disease Epidemiology epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Huntington's Disease Epidemiology  ... read more

QURE is a gene therapy company focusing on treatments for hemophilia, Huntington's disease and congestive heart failure. Next target: $35. Supernus Pharmaceuticals Inc. SUPN, -0.36% climbed 3%, or $1.70, to close at $48.05 on heavy volume of 923,900 shares traded Wednesday. The move is  ... read more

... also treat such diagnoses as arthritis, autism, Post-Traumatic Stress Disorder (PTSD), depression, Parkinson's disease, muscular dystrophy, complex regional pain syndrome, multiple sclerosis, cerebral palsy, neuropathy, microcephaly, amyotrophic lateral sclerosis (ALS), and Huntington's disease. ... read more

This could be important, he said, for using CRISPR to treat disease. Kmiec noted that while some ailments, like sickle cell anemia and Huntington's disease, involve faulty DNA within a single gene, others, like Alzheimer's and heart disease, appear to involve malfunctions in multiple genes where the  ... read more

“Global Huntington's Disease Partnering 2012 to 2018” tracks the major Partnering events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key Partnering players. Along with strategically analyzing the key micro  ... read more

Huntington's, an inherited disease that kills brain cells, is caused by a faulty gene. It can cause jerky movements and trouble walking, speaking and swallowing. Life expectancy is generally about 20 years after the person starts showing symptoms. Mr Hanly's grandfather, the celebrated Auckland painter  ... read more

Using cellular and animal models of Huntington's disease, the researchers have shown that high level of cytotoxic mutant Huntingtin protein triggers more glycogen synthesis in neurons by activating glycogen synthase. They observed that increased level of glycogen synthase protects neurons from the  ... read more

It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer's disease, Bipolar disorder, depression, epilepsy, Huntington's disease, Parkinson's disease and schizophrenia. Get a free copy of the Zacks research report  ... read more

Parkinson's Disease. Huntington's Disease. Headache Disorders. Stroke. Others. Invasive Brain Monitoring Device Market Report provides information about supply(Production), consumption, export, import revenue (million USD), market share and growth rate of Invasive Brain Monitoring Device in. ... read more

Parkinson's Disease. Huntington's Disease. Migraine. Stroke. Traumatic Brain Injuries. Sleep Disorders. Wireless Brain Sensors Market Report provides information about supply(Production), consumption, export, import revenue (million USD), market share and growth rate of Wireless Brain Sensors in. ... read more

Anna Marie Yanny is a graduate of the Behavioral Neuroscience undergraduate program at Western Washington University. Anna Marie believes that by crafting science into a digestible dialogue, we can include everyone in the conversation and find novel solutions. She conducts cognitive  ... read more

Drs Rachel Harding and Tam Maiuri are taking a leap of faith to make discoveries in Huntington's Disease (HD) research swift and open to all. They are publishing their lab notes on fundamental HD research online in real time, at the risk of losing credit for their work. As a ... read more

A group of researchers led by Leila Pirhaji, founder and CEO of ReviveMed and former postdoc at the Massachusetts Institute of Technology, published proof of concept for the company's technology in August 2016 in Nature Medicine, using Huntington's disease as a model. "Metabolomics data provide  ... read more

Sussex Healthcare has several facilities that can provide care for individuals with neurological and acquired brain-injury issues. A wide variety of conditions can be handled by the staff of Sussex Healthcare, including Huntington's disease, multiple sclerosis, motor neurone disease, Parkinson's disease,  ... read more

The firm offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington's disease, and symptomatic neurogenic orthostatic hypotension. Among 2 analysts covering H. ... read more

The research provides estimates and forecasts of Huntington's Disease prevalence, Huntington's Disease diagnosis rate, and Huntington's Disease treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and  ... read more

The research provides insights into Huntington's Disease epidemiology, Huntington's Disease diagnosed patients, and Huntington's Disease treatment rate for EU5 countries. The research measures key indicators including prevalence of Huntington's Disease derived from epidemiological analysis,  ... read more

The research study helps executives estimate Huntington's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify  ... read more

Huntington's disease. End-stage sclerops. End-stage Parkinson's disease. End-stage renal disease which cannot receive dialysis or transplantation. Quadriplegia with life-threatening complications. While none of us would wish to have one of these life shortening diseases, it's good to know that OPM  ... read more

According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's,  ... read more

The researcher announced the results of its Huntington's Disease patients study in a new research Europe Huntington's Disease Epidemiology and Patient Flow Analysis - 2018'. The research provides insights into Huntington's Disease epidemiology, Huntington's Disease diagnosed patients, and  ... read more

It's also developing candidates for neurodegenerative diseases such as Batten disease and Huntington's disease. The company has received an orphan drug designation for its SPK-TPP1 candidate for treating CLN2 disease in the United States. Additionally, Spark Therapeutics entered into a licensing  ... read more

While medications exist to lessen some of the movement and psychiatric symptoms of Huntington's disease, there are currently no treatments to halt the disease's progression. About 30,000 people in the United States are living with Huntington's disease, according to the National Institutes of Health. ... read more

The study includes a profound summary of the key sectors and the segments Epilepsy , Dementia , Parkinson’s Disease , Huntington's Disease , Migraine , Stroke , Traumatic Brain Injuries , Sleep Disorders of the Wireless Brain Sensors market. Both quickly and slowly growing sectors of the  ... read more

A new independent 72 page research with title 'Global Huntington's Disease Therapeutics Market 2014-2018' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like Americas, APAC, EMEA and important players/vendors such  ... read more

... facility, launched a £3.9million appeal last June to extend that support to 55 patients. The organisation provides round-the-clock care for those with a range of complex conditions, including motor neurone disease, acquired brain injury, Huntington's disease, Parkinson's disease and multiple sclerosis. ... read more

... cure all diseases involving tissue degeneration, including heart failure, spinal cord injury (actor Christopher “Superman” Reeves was a big supporter of stem cell research), stroke, burns, type 1 diabetes, osteoarthritis, rheumatoid arthritis, muscular dystrophy, Parkinson's disease, Huntington's disease,  ... read more

The organisation provides round-the-clock care for those with a range of complex conditions, including motor neurone disease, acquired brain injury, Huntington's disease, Parkinson's disease and multiple sclerosis. It has already raised more than half of its target, but former BP regional president,  ... read more

Mr Wright is on a disability pension for a genetic neurodegenerative disorder, commonly known as Huntington's disease. This was really my place for stress management. I had a routine and now he's killed my routine. I'm stressed and traumatised. Rathmines Street resident Barry Wright. He said it took  ... read more

Must have a terminal illness with a prognosis that it will end your life within the next six months, or; Suffer a grievous and irremediable condition, such as a degenerative disease like Huntington's Disease, at an advanced state of decline that is irreversible. The person must be experiencing unbearable  ... read more

Huntington's Disease Therapeutics Market report is carefully designed to help new entrants and the old players in the Huntington's Disease Therapeutics market to achieve their business and product goals. It will also be helpful to key executive (CEO and COO), potential investors, manufactures, strategy  ... read more

Patients suffering from this progressive (and fatal) brain deterioration are often diagnosed with Alzheimer's disease, Parkinson's, Huntington's disease and a list of others. There are 10 million new cases of dementia worldwide every year, according to the World Health Organization. The most common  ... read more

The firm offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington's disease, and symptomatic neurogenic orthostatic hypotension. Newcastle Investment Corp. operates  ... read more

The National Organisation for the Reform of Marijuana Laws wrote that “CBD lacks the consciousness-altering properties and abuse potential” of THC and argued there was evidence of “numerous medically beneficial properties” for people diagnosed with Parkinson's disease, Huntington's disease,  ... read more

Sidney Carter Award in Child Neurology: 'Spinal Muscular Atrophy is a Treatable Neurodegenerative Disease'; Presidential plenary session, oral presentation on Sunday, April 22, 10:45 a.m.-11:15 a.m.; 'Open Label Extension of the Phase 3 Study NEURO-TTR to Assess the Long-term Efficacy and  ... read more

The investigative therapy IONIS-HTTRx effectively reduced levels of the protein responsible for Huntington's disease in early-stage patients, according to the findings of an ongoing Phase 1/2 clinical trial. The results also revealed that IONIS-HTTRx is generally safe and well-tolerated by patients, further  ... read more

Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, will present key data on its amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) programs and on Huntington's  ... read more

CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) --. Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, will present key data on its amyotrophic lateral sclerosis (ALS) and  ... read more

The breadth of data spans a diverse set of patient populations including migraine, multiple sclerosis, tardive dyskinesia and Huntington's disease. ... “Teva's data at AAN embodies our expertise in researching and developing highly complex treatments for CNS disorders, especially those for which there  ... read more

Teva will also present AUSTEDO® (deutetrabenazine) tablets data providing clinical and real-world insights into the applicability of use across chorea associated with Huntington's disease and tardive dyskinesia in adults, two often underserved and overlooked movement disorders. The full set of  ... read more

Huntington's Disease Therapeutics Market report covers the present scenario and the growth prospects of the Huntington's Disease Therapeutics Market for 2017-2021. The report provides a basic overview of the Huntington's Disease Therapeutics Market including definitions, classifications,  ... read more

To laypersons, it might not seem obvious to search for the evolutionary origins of human intelligence in the genetics of Huntington's disease, or why doctors would want to test novel treatments for the cognitive symptoms of Parkinson's disease by measuring the reflex speeds of lab mice. But University of  ... read more

“A lot of patients that have other forms of anxiety disorders feel that cannabis has been helpful for that. And I do believe there's some research to support that. Certainly other states that have medical marijuana laws have a more inclusive list of diagnoses.” Miller adds that Huntington's disease – ... read more

SPARKLING UP LIVES: Huntington's Tasmania President Pam Cummings is thrilled that the Ulverstone Rotary Club is fundraising for her charity. Picture: Cordell ... Mrs Cummings said she wanted everyone to be aware of Huntington's Disease and that the NW Coast had the highest rates in the country. ... read more

North Valley Chapter of California Women for Agriculture: 6:30 p.m. Meets at alternating restaurants or member homes. email northvalleycwa@gmail.com. Third Tuesday. Huntington's Disease Support Group: 6:30 p.m. Help, sharing, education. Enloe Regional Cancer Center library, 265 Cohasset Road. ... read more

Additionally, the level of DA is highly related with some important neurologic diseases such as schizophrenia, Parkinson, and Huntington's diseases, etc. In light of the important roles that DA plays in the disease modulation, it is of considerable significance to develop a sensitive and reproducible  ... read more

The approved changes also will permit people with any terminal illnesses, neurodegenerative diseases and spinal cord damage to use medical marijuana. The original qualifying conditions were Lou Gehrig's disease, autism, cancer, Crohn's disease, epilepsy, glaucoma, HIV/AIDS, Huntington's disease  ... read more

Large, often fibril-type protein aggregates are in fact the most obvious pathological features of Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and other major neurodegenerative diseases. Many of the candidate drugs developed in recent years were designed to clear these protein  ... read more

Medical Xpress, Genetic Engineering and Biotechnology News, and Science News republished UW's release reporting that UW researchers have found that mice engineered to have Huntington's disease have an over-accumulation of iron in their mitochondria. Read UW's original release here. ... read more